We are live on ! Find out more
DWTX

Dogwood Therapeutics
DWTX

17 hedge funds and large institutions have $4.8M invested in Dogwood Therapeutics in 2022 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

13% more funds holding

Funds holding: 15 → 17 (+2)

0.02% more ownership

Funds ownership: 0.53% → 0.55% (+0.02%)

2% less capital invested

Capital invested by funds: $4.91M → $4.8M (-$105K)

Holders
17
Holders Change
+2
Holders Change %
+13.33%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
4
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Koshinski Asset Management
Koshinski Asset Management
Illinois
+$171K
2
P
&Partners
Tennessee
+$46K
3
State Street
State Street
Massachusetts
+$44.4K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$22.6K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$3.24K

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Advisers
Two Sigma Advisers
New York
-$65K
2
UBS Group
UBS Group
Switzerland
-$63K
3
BlackRock
BlackRock
New York
-$10.8K
4
TRCT
Tower Research Capital (TRC)
New York
-$4.81K
Name Holding Trade Value Shares
Change 		Change in
Stake
MCM
1
Masters Capital Management
Georgia
$2.75M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.02M – – –
CA
3
Cetera Advisors
Colorado
$186K – – –
Koshinski Asset Management
4
Koshinski Asset Management
Illinois
$173K +$171K +1,637 New
CAPTRUST Financial Advisors
5
CAPTRUST Financial Advisors
North Carolina
$170K – – –
Geode Capital Management
6
Geode Capital Management
Massachusetts
$136K +$3.24K +31 +2%
Susquehanna International Group
7
Susquehanna International Group
Pennsylvania
$97K +$22.6K +216 +31%
Northern Trust
8
Northern Trust
Illinois
$67K +$2.93K +28 +5%
BlackRock
9
BlackRock
New York
$65K -$10.8K -103 -14%
P
10
&Partners
Tennessee
$47K +$46K +440 New
State Street
11
State Street
Massachusetts
$45K +$44.4K +425 New
Morgan Stanley
12
Morgan Stanley
New York
$20K – – –
UWM
13
Urban Wealth Management
California
$10K +$10.2K +98 New
Osaic Holdings
14
Osaic Holdings
Arizona
$8K +$523 +5 +7%
TRCT
15
Tower Research Capital (TRC)
New York
$6K -$4.81K -46 -44%
Two Sigma Advisers
16
Two Sigma Advisers
New York
– -$65K -576 Closed
UBS Group
17
UBS Group
Switzerland
– -$63K -565 Closed
TIM
18
Tevis Investment Management
Texas
– +$314 +3 New

DWTX Hedge Fund Activity: Q2 2022 in Review

17 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in Dogwood Therapeutics (DWTX) for Q2 2022, worth a combined $4.8M — down 2.1% from $4.91M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new DWTX positions and 3 closed out — a net gain of 2 holders — while 4 added to existing stakes and 2 trimmed.

The largest buyer was Koshinski Asset Management, opening a new position worth an estimated $171K. The largest seller was Two Sigma Advisers, exiting entirely with an estimated $65K sold.

  • 17 institutional investors held Dogwood Therapeutics (DWTX) as of Q2 2022, up from 15 in Q1 2022.
  • Funds reported $4.8M of Dogwood Therapeutics stock for Q2 2022, down 2.1% quarter-over-quarter.
  • 5 funds opened new Dogwood Therapeutics positions in Q2 2022 and 3 closed out, a net change of +2 holders.
  • The largest Dogwood Therapeutics buyer in Q2 2022 was Koshinski Asset Management, an estimated $171K added.
  • The largest Dogwood Therapeutics seller in Q2 2022 was Two Sigma Advisers, an estimated $65K sold.

Based on aggregated 13F filings for Q2 2022.